Posted by Ashwini on February 02 2024 at 12:32 PM
public
Monoclonal antibodies market is experiencing significant growth, with a projected value of US$144,360 million by 2029 compared to US$105,790 million in 2022. This translates to a compound annual ...
Posted by Ashwini on February 01 2024 at 02:53 PM
public
Atopic Dermatitis Drugs market is expected to experience steady growth, reaching US$7,514.8 million by 2029, with a CAGR of 4.7% from 2023 to 2029.
To Know more about this report (Description, T...
The Biologics Contract Manufacturing Market is estimated to reach over $19 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of ~9% during the forecast period. In th...
Biologics are complex therapeutic products such as monoclonal antibodies, vaccines, blood components, genes, cells, and tissues that are manufactured or extracted from biological sources using biot...
Biologics are medications derived from living organisms such as microorganisms or mammalian cells. They are utilized for the treatment of various diseases including cancer, autoimmune diseases, and...
